BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 12040390)

  • 1. Rational Redesign of Inhibitors of Furin/kexin Processing Proteases.
    Ye YZ; Fei H; Ding DF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2001; 33(5):504-512. PubMed ID: 12040390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational redesign of inhibitors of furin/kexin processing proteases by electrostatic mutations.
    Cai XH; Zhang Q; Ding DF
    Acta Pharmacol Sin; 2004 Dec; 25(12):1712-818. PubMed ID: 15569420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Inhibitory Activities of Recombinant Eglin C Mutants on Kexin and Furin, Using Site-directed Mutagenesis and Molecular Modeling.
    Fei H; Luo MJ; Ye YZ; Ding DF; Chi CW
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2001; 33(6):591-599. PubMed ID: 12035048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered eglin c variants inhibit yeast and human proprotein processing proteases, Kex2 and furin.
    Komiyama T; Fuller RS
    Biochemistry; 2000 Dec; 39(49):15156-65. PubMed ID: 11106495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two engineered eglin c mutants potently and selectively inhibiting kexin or furin.
    Liu ZX; Fei H; Chi CW
    FEBS Lett; 2004 Jan; 556(1-3):116-20. PubMed ID: 14706837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of protease-inhibitor interactions by randomizing adventitious contacts.
    Komiyama T; VanderLugt B; Fugère M; Day R; Kaufman RJ; Fuller RS
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8205-10. PubMed ID: 12832612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for differences in substrate selectivity in Kex2 and furin protein convertases.
    Holyoak T; Kettner CA; Petsko GA; Fuller RS; Ringe D
    Biochemistry; 2004 Mar; 43(9):2412-21. PubMed ID: 14992578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonhistone protein purified from porcine kidney acts as a suicide substrate inhibitor on furin-like enzyme.
    Fei H; Li Y; Wang LX; Luo MJ; Ling MH; Chi CW
    Acta Pharmacol Sin; 2000 Mar; 21(3):265-70. PubMed ID: 11324429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.
    Qasim MA; Van Etten RL; Yeh T; Saunders C; Ganz PJ; Qasim S; Wang L; Laskowski M
    Biochemistry; 2006 Sep; 45(38):11342-8. PubMed ID: 16981694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptides derived from the prosegments of proprotein convertase 1/3 and furin are potent inhibitors of both enzymes.
    Basak A; Lazure C
    Biochem J; 2003 Jul; 373(Pt 1):231-9. PubMed ID: 12662153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of EGLIN C variants with the extended subsites of the precursor processing proteases.
    Komiyama T
    Protein Pept Lett; 2005 Jul; 12(5):415-20. PubMed ID: 16029153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage specificity of the serine protease of Aeromonas sobria, a member of the kexin family of subtilases.
    Kobayashi H; Takahashi E; Oguma K; Fujii Y; Yamanaka H; Negishi T; Arimoto-Kobayashi S; Tsuji T; Okamoto K
    FEMS Microbiol Lett; 2006 Mar; 256(1):165-70. PubMed ID: 16487335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human matriptase by eglin c variants.
    Désilets A; Longpré JM; Beaulieu ME; Leduc R
    FEBS Lett; 2006 Apr; 580(9):2227-32. PubMed ID: 16566926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing of alpha4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage.
    Bergeron E; Basak A; Decroly E; Seidah NG
    Biochem J; 2003 Jul; 373(Pt 2):475-84. PubMed ID: 12691605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Template-assisted rational design of peptide inhibitors of furin using the lysine fragment of the mung bean trypsin inhibitor.
    Tao H; Zhang Z; Shi J; Shao XX; Cui D; Chi CW
    FEBS J; 2006 Sep; 273(17):3907-14. PubMed ID: 16934032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative characterization of furin specificity. Energetics of substrate discrimination using an internally consistent set of hexapeptidyl methylcoumarinamides.
    Krysan DJ; Rockwell NC; Fuller RS
    J Biol Chem; 1999 Aug; 274(33):23229-34. PubMed ID: 10438496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semysinthetic biflavonoid Morelloflavone-7,4',7″,3‴,4‴-penta-O-butanoyl is a more potent inhibitor of Proprotein Convertases Subtilisin/Kexin PC1/3 than Kex2 and Furin.
    de Souza AA; de Andrade DM; Siqueira FDS; Di Iorio JF; Veloso MP; Coelho CM; Viegas Junior C; Gontijo VS; Dos Santos MH; Meneghetti MCZ; Nader HB; Tersariol ILDS; Juliano L; Juliano MA; Judice WAS
    Biochim Biophys Acta Gen Subj; 2021 Dec; 1865(12):130016. PubMed ID: 34560176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potent inhibitory activity of histone H1.2 C-terminal fragments on furin.
    Han J; Zhang L; Shao X; Shi J; Chi C
    FEBS J; 2006 Oct; 273(19):4459-69. PubMed ID: 16956366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating furin activity with designed mini-PDX peptides: synthesis and in vitro kinetic evaluation.
    Basak A; Lotfipour F
    FEBS Lett; 2005 Aug; 579(21):4813-21. PubMed ID: 16102752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.